Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 23, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - July 23, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/23/17 - Abbott Laboratories' Trademark Application for "PRO SCIENCE PUSH" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE PUSH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe, A
6/23/17 - AbbVie Announces Pivotal Phase 2 Trial Evaluating VENCLYXTO? (venetoclax) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion to be Presented at 22nd European Hematology Association (EHA) Annual Congress
AbbVie, a global biopharmaceutical company, today announced the presentation of results from the pivotal Phase 2 study of VENCLYXTO?, a first-in-class oral B-cell lymphoma-2 inhibitor. VENCLYXTO monotherapy was granted conditional marketing authorization in the EU for the treatment of CLL in the presence of 17 p deletion or TP53 mutation in adu
6/23/17 - Advanced Infusion Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024
The key factors that are driving the advanced infusion systems market are the overall growth in the global population that are suffering from diabetes, cancer, and chronic disease.Sarasota, FL 06/22/2017 Zion Market Research, the market research group announced the analysis report titled " Advanced Infusion Systems Market: Global Industry Ana
6/23/17 - Amid Reports that Trump Will Break Promise to Get Tough on Drug Pricing, Booker, Franken, Lawmakers Urge Trump to Act on Solutions that Bring Down...
Washington, DC- With news reports indicating the White House is on the verge of issuing an executive order devoid of policies that would meaningfully reduce prescription drug prices, breaking yet another key promise to Americans, Sen. Cory Booker joined Sen. Al Franken and other Senate and House Democrats to urge President Donald Trump to act on so
6/23/17 - An Application for the Trademark "ENSURE HEALTHY MATTERS" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENSURE HEALTHY MATTERS" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona,
6/23/17 - An Application for the Trademark "PRO SCIENCE FINISH" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE FINISH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe,
6/23/17 - Another View Drug importation would worsen the opioid crisis
Bernie Sanders is sponsoring a bill that would allow people to import packages of prescription drugs from Canada. Maggie Hassan, New Jersey Sen. Cory Booker, and Minnesota Sen. Al Franken also support the bill.
6/23/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report (Jun. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on June 2, 2017. The SEC file number is 0001171843-17-003427.. A U.S. Securities and Exchange Commission filing is a formal d
6/23/17 - As White House Prepares Gift to Big Pharma, Rep. Schakowsky and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down...
Schakowsky and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Rep. Jan Schakowsky, a Chief Deputy Whip, led a wide group of House and Senate Democrats i
6/23/17 - As White House Prepares Gift to Big Pharma, Sen. Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription...
Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Sen. Al Franken led a wide group of Senate and House Democrats in pushing President Donald Tr
6/23/17 - Astellas president wants people to focus on lives saved by pharmaceutical industry [Chicago Tribune]
June 22 Jim Robinson just wrapped up his first year as president of Astellas Americas and it was quite a year for the pharmaceutical industry. Robinson, 47, is based in Northbrook, where he heads North and South American operations for Japanese drugmaker Astellas Pharma. A: Mark Kaufman and Mary Ann Kaufman, his wife, are responsible for me bei
6/23/17 - Benitec Biopharma Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jun. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Benitec Biopharma Ltd was posted on June 2, 2017. The SEC file number is 0001144204-17-030718.. A U.S. Securities and Exchange Commission filing is a formal doc
6/23/17 - Benitec Biopharma Ltd Files SEC Form F-3, Registration Statement By Foreign Private Issuers (Jun. 1, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Benitec Biopharma Ltd was posted on June 1, 2017. The SEC file number is 0001193125-17-190236.. A U.S. Securities and Exchange Commission filing is a formal doc
6/23/17 - Bipartisan Group of Members of Senate Judiciary Committee Urge FDA Commissioner to Address Abuses in Regulatory Process That Delay Competition, Increase Prescription Drug Costs
Commissioner Gottlieb recently stated that the FDA will take measures to curb anticompetitive abuses of its regulatory process for the approval of generic drugs. In their letter, the senators advocate for their legislative solution and ask Commissioner Gottlieb to detail the regulatory actions the FDA can and cannot take to address strategies that.
6/23/17 - Bipartisan Group of Senators Urge FDA Commissioner to Address Prescription Drug Costs
Commissioner Gottlieb recently stated that the FDA will take measures to curb anticompetitive abuses of its regulatory process for the approval of generic drugs. In their letter, the senators advocate for their legislative solution and ask Commissioner Gottlieb to detail the regulatory actions the FDA can and cannot take to address strategies that.
6/23/17 - Can-fite Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jun. 1, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Can-fite Biopharma Ltd. was posted on June 1, 2017. The SEC file number is 0001213900-17-006037.. A U.S. Securities and Exchange Commission filing is a formal d
6/23/17 - Cardiovascular Outcomes Trial of Anti-Obesity Agent Lorcaserin to Continue Based on Recommendation of Independent Data Monitoring Committee After Completion of Interim Safety Analysis
This Phase IIIb/IV clinical study, comprised of 12,000 patients, is being conducted over a 5- year period in partnership with the Thrombolysis in Myocardial Infarction Study Group and is intended to address the post-marketing requirement from the U.S. Food and Drug Administration to evaluate the long-term cardiovascular safety of lorcaserin.
6/23/17 - CARsgen Therapeutics Presented at the 2017 BIO International Convention
SAN DIEGO, June 23, 2017/ PRNewswire/ CARsgen Therapeutics, a global biotech start-up focused on developing chimeric antigen receptor T-cell therapies for solid tumors, presented at the 2017 BIO International Convention this week in San Diego, CA.. For its progress on cancer immunotherapy, typically for CAR-T therapies to treat solid tumors, CARs
6/23/17 - Cti Biopharma Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)] (Jun. 5, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on June 5, 2017. The SEC file number is 0001193125-17-194653.. A U.S. Securities and Exchange Commission filing is a formal docum
6/23/17 - Cti Biopharma Corp. Files SEC Form 8-K, Current Report (Jun. 5, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on June 5, 2017. The SEC file number is 0000891293-17-000061.. A U.S. Securities and Exchange Commission filing is a formal docum
6/23/17 - Cti Biopharma Corp. Files SEC Form FWP, Filing Under Securities Act Rules 163/433 of Free Writing Prospectuses (Jun. 6, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on June 6, 2017. The SEC file number is 0001193125-17-195470.. A U.S. Securities and Exchange Commission filing is a formal docum
6/23/17 - Data from Singapore National University Provide New Insights into Drug Delivery Systems (Directing Assembly and Disassembly of 2D MoS2 Nanosheets...
By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. According to news reporting originating in Singapore, Singapore, by NewsRx journalists, research stated, "Layer-by-layer self-assembled stacked Testudo-like MoS2 superstructures carrying cancer drugs are formed from nanoshe
6/23/17 - Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring [Tehran Times (Iran)]
Donald Trump campaigned on reining in sky-high drug prices, and as recently as January, he said the industry was "getting away with murder." In the U.S., low-cost generic drugs represent nearly 90% of prescription-drug volume, yet high-cost specialty drugs used in indications such as cancer account for an increasingly larger share of total spending
6/23/17 - Dr. Reddy's Laboratories Announces the Launch of Bivalirudin for Injection in the U.S. Market
By a News Reporter-Staff News Editor at Drug Week Dr. Reddy's Laboratories Ltd. announced that it has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic equivalent generic version of Angiomax for Injection, approved by the U.S. Food and Drug Administration. The Angiomax brand and generic had U.S. sales of approximately $198 mill
6/23/17 - Eli Lilly's Trademark Application for "ZYPREXA RELPREVV" Filed
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ZYPREXA RELPREVV" by Robert E. Lee, Jr., representing Eli Lilly. The owner/registrar information for this application is: Robert E. Lee, Jr., Eli Lilly, Lilly Corporate
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415